- Home
- ARWR vs DV Comparison
ARWR vs DV Comparison
Compare ARWR & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- DV
- Stock Information
- Founded
- ARWR 2003
- DV 2008
- Country
- ARWR United States
- DV United States
- Employees
- ARWR N/A
- DV N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- DV Computer Software: Prepackaged Software
- Sector
- ARWR Health Care
- DV Technology
- Exchange
- ARWR Nasdaq
- DV Nasdaq
- Market Cap
- ARWR 1.8B
- DV 2.4B
- IPO Year
- ARWR 1993
- DV 2021
- Fundamental
- Price
- ARWR $18.31
- DV $14.65
- Analyst Decision
- ARWR Buy
- DV Buy
- Analyst Count
- ARWR 8
- DV 18
- Target Price
- ARWR $43.71
- DV $18.92
- AVG Volume (30 Days)
- ARWR 1.6M
- DV 2.4M
- Earning Date
- ARWR 08-07-2025
- DV 08-05-2025
- Dividend Yield
- ARWR N/A
- DV N/A
- EPS Growth
- ARWR N/A
- DV N/A
- EPS
- ARWR N/A
- DV 0.29
- Revenue
- ARWR $545,209,000.00
- DV $681,128,000.00
- Revenue This Year
- ARWR $21,924.50
- DV $15.65
- Revenue Next Year
- ARWR N/A
- DV $11.67
- P/E Ratio
- ARWR N/A
- DV $50.03
- Revenue Growth
- ARWR 1436.97
- DV 15.30
- 52 Week Low
- ARWR $9.57
- DV $11.52
- 52 Week High
- ARWR $30.41
- DV $23.11
- Technical
- Relative Strength Index (RSI)
- ARWR 66.51
- DV 47.70
- Support Level
- ARWR $16.45
- DV $15.19
- Resistance Level
- ARWR $19.24
- DV $15.66
- Average True Range (ATR)
- ARWR 0.79
- DV 0.37
- MACD
- ARWR 0.25
- DV -0.01
- Stochastic Oscillator
- ARWR 77.43
- DV 39.20
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.